Elahere News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Elahere. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Elahere Today - Breaking & Trending Today

Modesitt Spotlights the Latest ADC Breakthroughs in Gynecologic Oncology

Susan C. Modesitt, MD, FACOG, FACS, sheds light on the latest research with antibody-drug conjugates across gynecologic cancers. ....

Emory University , United States , Susanc Modesitt , National Comprehensive Cancer Network , Winship Cancer Institute Of Emory University , Onclive State , Science Summit , Winship Cancer Institute , Gynecologic Oncology , Emory University School , Antibody Drug Conjugates , Onclive State Of The Science Summit , Trop2 And Her2 Targeted Adcs , Minimizing Toxicities , Mirvetuximab Soravtansine , Trastuzumab Deruxtecan , Sacituzumab Govitecan , Tisotumab Vedotin ,

To engineer Elahere: Abbvie sees bright future in $10B Immunogen takeover

Buying out Immunogen Inc. in a whopper cash deal valued at about $10.1 billion, Abbvie Inc. has major plans for an expanded label on the antibody-drug conjugate Elahere (mirvetuximab soravtansine-gynx), already approved for treating platinum-resistant ovarian cancer. ....

Abbvie Inc , Immunogen Inc , Immunogen Inc , Abbvie Inc , Mirvetuximab Soravtansine , Ovarian Cancer ,